{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:36:16Z","timestamp":1793068576657,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tokat Gaziosmanpa\u015fa University, Foundation of Scientific Researches Projects","award":["Project number: 2022\/82"],"award-info":[{"award-number":["Project number: 2022\/82"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09562-x","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T17:01:58Z","timestamp":1714669318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Apoptotic effect of 5-fluorouracil-doxorubicin combination on colorectal cancer cell monolayers and spheroids"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-5434","authenticated-orcid":false,"given":"Sema","family":"Bilgin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"6","key":"9562_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2017.04.008","volume":"3","author":"D Rosel","year":"2017","unstructured":"Rosel D, Sanz-Moreno V, Fernandes M, Heneberg P, Vesel\u00fd P, Br\u00e1bek J, Petru\u017eelka L, Kumar S, \u010cerm\u00e1k V, Gandalovi\u010dov\u00e1 A (2017) Migrastatics\u2014anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer 3(6):391\u2013406. https:\/\/doi.org\/10.1016\/j.trecan.2017.04.008","journal-title":"Trends Cancer"},{"key":"9562_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147408","author":"D Duarte","year":"2021","unstructured":"Duarte D, Cardoso A, Vale N (2021) Synergistic growth inhibition of HT-29 colon and MCF-7 breast cancer cells with simultaneous and sequential combinations of antineoplastics and CNS drugs. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22147408","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9562_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7150\/IJMS.66737","volume":"19","author":"RH Gong","year":"2022","unstructured":"Gong RH, Yang DJ, Kwan HY, Lyu AP, Chen GQ, Bian ZX (2022) Cell death mechanisms induced by synergistic effects of halofuginone and artemisinin in colorectal cancer cells. Int J Med Sci 19(1):175\u2013185. https:\/\/doi.org\/10.7150\/IJMS.66737","journal-title":"Int J Med Sci"},{"key":"9562_CR4","doi-asserted-by":"publisher","first-page":"111704","DOI":"10.1016\/j.biopha.2021.111704","volume":"140","author":"C Karthika","year":"2021","unstructured":"Karthika C, Hari B, Rahman MH, Akter R, Najda A, Albadrani GM, Sayed AA, Akhtar MF, Abdel-Daim MM (2021) Multiple strategies with the synergistic approach for addressing colorectal cancer. Biomed Pharmacother 140:111704. https:\/\/doi.org\/10.1016\/j.biopha.2021.111704","journal-title":"Biomed Pharmacother"},{"issue":"11","key":"9562_CR5","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1158\/0008-5472.CAN-14-3763","volume":"75","author":"JC Ashton","year":"2015","unstructured":"Ashton JC (2015) Drug combination studies and their synergy quantification using the chou-talalay method-letter. Can Res 75(11):2400. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3763","journal-title":"Can Res"},{"key":"9562_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3390\/biomedicines11041058","volume":"11","author":"MT Elena","year":"2023","unstructured":"Elena MT, Davide R, Daniele F, Paolo M (2023) Replacement, reduction, and refinement of animal experiments in anticancer drug development: the contribution of 3D in vitro cancer models in the drug efficacy assessment. Biomedicines 11:1058. https:\/\/doi.org\/10.3390\/biomedicines11041058","journal-title":"Biomedicines"},{"key":"9562_CR7","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"S Vodenkova","year":"2020","unstructured":"Vodenkova S, Buchler T, Cervena K, Veskrnova V, Vodicka P, Vymetalkova V (2020) 5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future. Pharmacol Ther 206:107447. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107447","journal-title":"Pharmacol Ther"},{"issue":"5","key":"9562_CR8","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1007\/s00018-008-8557-5","volume":"66","author":"MD Wyatt","year":"2009","unstructured":"Wyatt MD, Wilson DM (2009) Participation of DNA repair in the response to 5-fluorouracil. Cell Mol Life Sci 66(5):788\u2013799. https:\/\/doi.org\/10.1007\/s00018-008-8557-5","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"9562_CR9","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1111\/cas.14532","volume":"111","author":"S Blondy","year":"2020","unstructured":"Blondy S, David V, Verdier M, Mathonnet M, Perraud A, Christou N (2020) 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes. Cancer Sci 111(9):3142\u20133154. https:\/\/doi.org\/10.1111\/cas.14532","journal-title":"Cancer Sci"},{"key":"9562_CR10","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.3390\/molecules27144478","volume":"27","author":"P Sijongesonke","year":"2022","unstructured":"Sijongesonke P, Sibusiso A, Rejoice BM, Blessing AA (2022) Doxorubicin-based hybrid compounds as potential anticancer agents: a review. Molecules 27:4478. https:\/\/doi.org\/10.3390\/molecules27144478","journal-title":"Molecules"},{"issue":"3","key":"9562_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00280-022-04400-y","volume":"89","author":"RE Nicoletto","year":"2022","unstructured":"Nicoletto RE, Ofner CM (2022) Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells. Cancer Chemother Pharmacol 89(3):285\u2013311. https:\/\/doi.org\/10.1007\/s00280-022-04400-y","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"9562_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","volume":"65","author":"O Tacar","year":"2013","unstructured":"Tacar O, Sriamornsak P, Dass CR (2013) Doxorubicin: An update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2):157\u2013170. https:\/\/doi.org\/10.1111\/j.2042-7158.2012.01567.x","journal-title":"J Pharm Pharmacol"},{"key":"9562_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ijbiomac.2021.12.181","volume":"201","author":"E Ranjbar","year":"2021","unstructured":"Ranjbar E, Namazi H, Pooresmaeil M (2021) (2022) Carboxymethyl starch encapsulated 5-FU and DOX co-loaded layered double hydroxide for evaluation of its in vitro performance as a drug delivery agent. Int J Biol Macromol 201:193\u2013202. https:\/\/doi.org\/10.1016\/j.ijbiomac.2021.12.181","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"9562_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-31-60","volume":"31","author":"M Lamberti","year":"2012","unstructured":"Lamberti M, Porto S, Marra M, Zappavigna S, Grimaldi A, Feola D, Pesce D, Naviglio S, Spina A, Sannolo N, Caraglia M (2012) 5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress. J Exp Clin Cancer Res 31(1):1\u20138. https:\/\/doi.org\/10.1186\/1756-9966-31-60","journal-title":"J Exp Clin Cancer Res"},{"key":"9562_CR15","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.adcanc.2024.100114","volume":"10","author":"A Sumel","year":"2024","unstructured":"Sumel A, Mithun B, Radheshyam P, Heya K, Prashant K, Himanshu S, Ashish G, Shubneesh K, Ushasi D (2024) Multi drug resistance in colorectal Cancer- approaches to overcome, advancements and future success. Adv Cancer Biol Metastasis 10:100114. https:\/\/doi.org\/10.1016\/j.adcanc.2024.100114","journal-title":"Adv Cancer Biol Metastasis"},{"issue":"2","key":"9562_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10238-011-0146-5","volume":"12","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Yuan J, Zhang HY, Simayi D, Li PD, Wang YH, Li F, Zhang WJ (2012) Natural resistance to apoptosis correlates with resistance to chemotherapy in colorectal cancer cells. Clin Exp Med 12(2):97\u2013103. https:\/\/doi.org\/10.1007\/s10238-011-0146-5","journal-title":"Clin Exp Med"},{"key":"9562_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2074-7","volume":"1250","author":"M Vinken","year":"2015","unstructured":"Vinken M, Rogiers V (2015) Protocols in in vitro hepatocyte research. Protoc In Vitro Hepatocyte Res 1250:1\u2013390. https:\/\/doi.org\/10.1007\/978-1-4939-2074-7","journal-title":"Protoc In Vitro Hepatocyte Res"},{"issue":"3","key":"9562_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC (2006) Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 58(3):621\u2013681. https:\/\/doi.org\/10.1124\/pr.58.3.10","journal-title":"Pharmacol Rev"},{"issue":"3","key":"9562_CR19","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao X, Huang X, Zhou Z, Lin X (2013) An improvement of the 2\u02c6(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinform Biomath 3(3):71\u201385","journal-title":"Biostat Bioinform Biomath"},{"issue":"1","key":"9562_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-022-02561-7","volume":"22","author":"H Moutabian","year":"2022","unstructured":"Moutabian H, Majdaeen M, Ghahramani-Asl R, Yadollahi M, Gharepapagh E, Ataei G, Falahatpour Z, Bagheri H, Farhood B (2022) A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities. Cancer Cell Int 22(1):1\u201314. https:\/\/doi.org\/10.1186\/s12935-022-02561-7","journal-title":"Cancer Cell Int"},{"issue":"5","key":"9562_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1159\/000011897","volume":"55","author":"C Katona","year":"1998","unstructured":"Katona C, Kralov\u00e1nszky J, Rosta A, Pandi E, F\u00f3nyad G, T\u00f3th K, Jeney A (1998) Putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-fluorouracil in colorectal cancer patients. Oncology 55(5):468\u2013474. https:\/\/doi.org\/10.1159\/000011897","journal-title":"Oncology"},{"issue":"22","key":"9562_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/MOLECULES25225265","volume":"25","author":"IB Toumia","year":"2020","unstructured":"Toumia IB, Sobeh M, Ponassi M, Banelli B, Dameriha A, Wink M, Ghedira LC, Rosano C (2020) A methanol extract of scabiosa atropurpurea enhances doxorubicin cytotoxicity against resistant colorectal cancer cells in vitro. Molecules 25(22):1\u201312. https:\/\/doi.org\/10.3390\/MOLECULES25225265","journal-title":"Molecules"},{"key":"9562_CR23","doi-asserted-by":"publisher","first-page":"111285","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN (2021) 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: implication of DNA repair inhibition. Biomed Pharmacother 137:111285. https:\/\/doi.org\/10.1016\/j.biopha.2021.111285","journal-title":"Biomed Pharmacother"},{"key":"9562_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijbiomac.2022.12.244","volume":"228","author":"Y Lu","year":"2022","unstructured":"Lu Y, Chen Z, Lin Q, Xia X, Lin Y, Yan J, Huang M, Huang R (2022) (2023) Anti-colon cancer effects of Spirulina polysaccharide and its mechanism based on 3D models. Int J Biol Macromol 228:559\u2013569. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.12.244","journal-title":"Int J Biol Macromol"},{"key":"9562_CR25","doi-asserted-by":"publisher","first-page":"122408","DOI":"10.1016\/j.biomaterials.2023.122408","volume":"304","author":"X Renjian","year":"2024","unstructured":"Renjian X, Vaibhav P, Yanrong Y, Xiaolu L, Mengwei G, Shijie L, Miao H, Weijie P, Ibrahim TO (2024) A comprehensive review on 3D tissue models: biofabrication technologies and preclinical applications. Biomaterials 304:122408. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122408","journal-title":"Biomaterials"},{"issue":"6","key":"9562_CR26","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.3892\/ijo.2016.3467","volume":"48","author":"B Galateanu","year":"2016","unstructured":"Galateanu B, Hudita A, Negrei C, Ion RM, Costache M, Stan M, Nikitovic D, Hayes AW, Spandidos DA, Tsatsakis AM, Ginghina O (2016) Impact of multicellular tumor spheroids as an in vivo-like tumor model on anticancer drug response. Int J Oncol 48(6):2295\u20132302. https:\/\/doi.org\/10.3892\/ijo.2016.3467","journal-title":"Int J Oncol"},{"issue":"3","key":"9562_CR27","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1039\/c0an00609b","volume":"136","author":"YC Tung","year":"2011","unstructured":"Tung YC, Hsiao AY, Allen SG, Torisawa YS, Ho M, Takayama S (2011) High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst 136(3):473\u2013478. https:\/\/doi.org\/10.1039\/c0an00609b","journal-title":"Analyst"},{"issue":"1","key":"9562_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-10-38","volume":"10","author":"K Chitcholtan","year":"2012","unstructured":"Chitcholtan K, Sykes PH, Evans JJ (2012) The resistance of intracellular mediators to doxorubicin and cisplatin are distinct in 3D and 2D endometrial cancer. J Transl Med 10(1):1\u201316. https:\/\/doi.org\/10.1186\/1479-5876-10-38","journal-title":"J Transl Med"},{"issue":"1","key":"9562_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0244513","volume":"16","author":"J Koch","year":"2021","unstructured":"Koch J, M\u00f6nch D, Maa\u00df A, Gromoll C, Hehr T, Leibold T, Schlitt HJ, Dahlke MH, Renner P (2021) Three dimensional cultivation increases chemo- and radioresistance of colorectal cancer cell lines. PLoS ONE 16(1):1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0244513","journal-title":"PLoS ONE"},{"key":"9562_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s12195-024-00798-y","author":"L Astha","year":"2024","unstructured":"Astha L, Hossein T (2024) Three-dimensional tumor models to study cancer stemness-mediated drug resistance. Cell Mol Bioeng. https:\/\/doi.org\/10.1007\/s12195-024-00798-y","journal-title":"Cell Mol Bioeng"},{"key":"9562_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"W Haolan","year":"2023","unstructured":"Haolan W, Ming G, Hudie W, Yongheng C (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther 8:92. https:\/\/doi.org\/10.1038\/s41392-023-01347-1","journal-title":"Signal Transduct Target Ther"},{"key":"9562_CR32","doi-asserted-by":"publisher","first-page":"103329","DOI":"10.1016\/j.bioorg.2019.103329","volume":"93","author":"MH Ahagh","year":"2019","unstructured":"Ahagh MH, Dehghan G, Mehdipour M, Teimuri-Mofrad R, Payami E, Sheibani N, Ghaffari M, Asadi M (2019) Synthesis, characterization, anti-proliferative properties and DNA binding of benzochromene derivatives: Increased Bax\/Bcl-2 ratio and caspase-dependent apoptosis in colorectal cancer cell line. Bioorg Chem 93:103329. https:\/\/doi.org\/10.1016\/j.bioorg.2019.103329","journal-title":"Bioorg Chem"},{"issue":"6","key":"9562_CR33","doi-asserted-by":"publisher","first-page":"118688","DOI":"10.1016\/j.bbamcr.2020.118688","volume":"1867","author":"A Boice","year":"2020","unstructured":"Boice A, Bouchier-Hayes L (2020) Targeting apoptotic caspases in cancer. Biochim Biophys Acta\u2014Mol Cell Res 1867(6):118688. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118688","journal-title":"Biochim Biophys Acta\u2014Mol Cell Res"},{"key":"9562_CR34","doi-asserted-by":"publisher","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","volume":"60","author":"S Gayatri","year":"2023","unstructured":"Gayatri S, \u00b7 Dibyaranjan S, Pratima K, Meesala KM, (2023) A Review on caspases: key regulators of biological activities and apoptosis. Mol Neurobiol 60:5805\u20135837. https:\/\/doi.org\/10.1007\/s12035-023-03433-5","journal-title":"Mol Neurobiol"},{"issue":"6","key":"9562_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/tox.23105","volume":"36","author":"MFS Jadid","year":"2021","unstructured":"Jadid MFS, Aghaei E, Taheri E, Seyyedsani N, Chavoshi R, Abbasi S, Khorrami A, Goleij P, Hajazimian S, Taefehshokr S, Isazadeh A, Shanehbandi D (2021) Melatonin increases the anticancer potential of doxorubicin in Caco-2 colorectal cancer cells. Environ Toxicol 36(6):1061\u20131069. https:\/\/doi.org\/10.1002\/tox.23105","journal-title":"Environ Toxicol"},{"key":"9562_CR36","doi-asserted-by":"publisher","first-page":"18380","DOI":"10.1038\/s41598-023-45144-w","volume":"13","author":"NA Zaid","year":"2023","unstructured":"Zaid NA, Ali ZAS, Saba MJ, Ghassan MS (2023) Comparative analysis between 2D and 3D colorectal cancer culture models for insights into cellular morphological and transcriptomic variations. Sci Rep 13:18380. https:\/\/doi.org\/10.1038\/s41598-023-45144-w","journal-title":"Sci Rep"},{"key":"9562_CR37","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.redox.2021.102144","volume":"47","author":"C Yang","year":"2021","unstructured":"Yang C, Song J, Hwang S, Choi J, Song G, Lim W (2021) Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells. Redox Biol 47:102144. https:\/\/doi.org\/10.1016\/j.redox.2021.102144","journal-title":"Redox Biol"},{"issue":"9","key":"9562_CR38","doi-asserted-by":"publisher","first-page":"103392","DOI":"10.1016\/j.sjbs.2022.103392","volume":"29","author":"NM Alhoshani","year":"2022","unstructured":"Alhoshani NM, Al-Johani NS, Alkeraishan N, Alarifi S, Alkahtani S (2022) Effect of lycopene as an adjuvant therapy with 5-florouracil in human colon cancer. Saudi J Biol Sci 29(9):103392. https:\/\/doi.org\/10.1016\/j.sjbs.2022.103392","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"9562_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.26689\/par.v8i1.5911","volume":"8","author":"D Rui","year":"2024","unstructured":"Rui D (2024) p53 Contributes to the chemotherapeutic drug doxorubicin-induced cell death in colorectal cancer cell line HCT116. Proc Anticancer Res 8(1):112","journal-title":"Proc Anticancer Res"},{"issue":"5","key":"9562_CR40","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.bcp.2005.11.026","volume":"71","author":"L Li","year":"2006","unstructured":"Li L, Lu Q, Shen Y, Hu X (2006) Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells. Biochem Pharmacol 71(5):584\u2013595. https:\/\/doi.org\/10.1016\/j.bcp.2005.11.026","journal-title":"Biochem Pharmacol"},{"issue":"24","key":"9562_CR41","doi-asserted-by":"publisher","first-page":"25535","DOI":"10.1074\/jbc.M400944200","volume":"279","author":"S Wang","year":"2004","unstructured":"Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B (2004) Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms: Intermediacy of H2O2 and p53-dependent pathways. J Biol Chem 279(24):25535\u201325543. https:\/\/doi.org\/10.1074\/jbc.M400944200","journal-title":"J Biol Chem"},{"issue":"1","key":"9562_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.22034\/APJCP.2018.19.1.131","volume":"19","author":"NN Sarvestani","year":"2018","unstructured":"Sarvestani NN, Sepehri H, Delphi L, Farimani MM (2018) Eupatorin and Salvigenin potentiate doxorubicin-induced apoptosis and cell cycle arrest in HT-29 and SW948 human colon cancer cells. Asian Pac J Cancer Prev 19(1):131\u2013139. https:\/\/doi.org\/10.22034\/APJCP.2018.19.1.131","journal-title":"Asian Pac J Cancer Prev"},{"key":"9562_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/biohorizons\/hzw005","volume":"9","author":"HR Warren","year":"2016","unstructured":"Warren HR, Hejmadi M (2016) Effect of hypoxia on chemosensitivity to 5-fluorouracil in SH-SY5Y neuroblastoma cells. Biosci Horizons 9:1\u20139. https:\/\/doi.org\/10.1093\/biohorizons\/hzw005","journal-title":"Biosci Horizons"},{"issue":"03","key":"9562_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/s1098-8859(03)00002-8","volume":"8859","author":"W Zhang","year":"2003","unstructured":"Zhang W (2003) Genetic control of interleukin-4\u2013induced activation of the human signal transducer and activator of transcription 6 signaling pathway. Hum Immunol 8859(03):2\u20138. https:\/\/doi.org\/10.1016\/s1098-8859(03)00002-8","journal-title":"Hum Immunol"},{"issue":"2","key":"9562_CR45","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bbrc.2008.02.052","volume":"369","author":"BH Li","year":"2008","unstructured":"Li BH, Yang XZ, Li PD, Yuan Q, Liu XH, Yuan J, Zhang WJ (2008) IL-4\/Stat6 activities correlate with apoptosis and metastasis in colon cancer cells. Biochem Biophys Res Commun 369(2):554\u2013560. https:\/\/doi.org\/10.1016\/j.bbrc.2008.02.052","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09562-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09562-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:03:58Z","timestamp":1738724638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09562-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9562"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09562-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"603"}}